MarketInOut Stock Screener Log In | Sign Up
 

Regencell Bioscience Holdings Ltd

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 05/29/2026
Regencell Bioscience Holdings Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11,724 mln
Float55.41 mln
Earnings Date06/02/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

3 / 100
Severely lagging

Debt / Equity

0.45
Low leverage

ROE

-165
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Regencell Bioscience Holdings Limited is a Hong Kong-based company dedicated to advancing Traditional Chinese Medicine as a modern treatment option. Founded in 2014 and based in Causeway Bay, the company applies scientific research to develop and bring to market remedies targeting brain and cognitive conditions, with a particular focus on ADHD and autism spectrum disorder.

Key Fundamentals

EPS-0.01
ROE-165
ROIC-184
ROA-130
EBITDA, mln-7.13
EV / EBITDA-1,706
EV / EBIT-1,706

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio7.72
Short % of Float1.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -11.48% 1 / 100   
1 Month -17.44% 3 / 100   
2 Months -18.07% 8 / 100   
6 Months 112% 99 / 100   
1 Year 74.71% 91 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us